depression and semaglutide GLP-1s linked to lower rates of anxiety than an older anti-obesity drug — not higher. #GLP1 #Semaglutide #Tirzepatide #ObesityMedicine #MentalHealth #Anxiety #Depression #Neuropsychiatry #ObesityTreatment #WeightManagement #Naltrexone Most GLP-1 Medications Correlated with

Images are increasingly being used in journals to demonstrate results, and the manipulation of images in published papers appears to be rife

Medical malpractice policies can cover claims arising from treatments performed while your insurance was active

doi: 10.3390/biomedicines11112993

Additionally, on April 30, 2026, one of Novo Nordisks competitors completed phase three of a clinical trial of a drug that they hope will help people lose weight and reduce liver fat. The clinical trial involved people who have obesity or are overweight and have also been diagnosed with a specific type of liver disease

For glaucoma and eye problems: BPC-157 has shown efficacy in many animal studies and a couple of preclinical trials for eye problems

Thirty-day oral gavage exposure to PET NPs (mean diameter 62 nm